ExodusPoint Capital Management’s Zimmer Biomet ZBH Stock Holding History

ExodusPoint Capital Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-30,900	Closed	-$3.58M	–	2293
2020 Q2	$3.58M	Buy	+30,900	New	+$3.56M	0.09%	236

Other funds holding ZBH

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

ExodusPoint Capital Management's ZBH Position: Q2 2026 in Review

ExodusPoint Capital Management increased its Zimmer Biomet (ZBH) stake by 87% in Q2 2026, buying an estimated $7.39M and bringing the position to 180,884 shares worth $15.6M. The position accounts for 0.1% of the portfolio, ranked #186.

ExodusPoint Capital Management first reported a position in ZBH in Q4 2018 and has held it in 22 quarters since. The position peaked at $39M in Q4 2023. 911 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

ExodusPoint Capital Management held 180,884 shares of Zimmer Biomet worth $15.6M as of Q2 2026.
ExodusPoint Capital Management bought 84,284 Zimmer Biomet shares in Q2 2026, an estimated $7.39M.
Zimmer Biomet made up 0.1% of ExodusPoint Capital Management's portfolio in Q2 2026, its #186 holding.
ExodusPoint Capital Management first reported a position in Zimmer Biomet in Q4 2018 and has held it in 22 quarters since.
ExodusPoint Capital Management's Zimmer Biomet position peaked at $39M in Q4 2023.
911 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.